Public Sector Pension Investment Board cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 47.6% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,916 shares of the medical equipment provider's stock after selling 51,727 shares during the quarter. Public Sector Pension Investment Board's holdings in Intuitive Surgical were worth $24,062,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the company. Bank of New York Mellon Corp purchased a new stake in Intuitive Surgical during the 2nd quarter valued at $1,335,753,000. Arrowstreet Capital Limited Partnership grew its stake in shares of Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock worth $970,635,000 after acquiring an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. grew its stake in shares of Intuitive Surgical by 55.8% in the third quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider's stock worth $633,505,000 after acquiring an additional 558,099 shares during the period. Mirae Asset Global Investments Co. Ltd. purchased a new stake in Intuitive Surgical during the 3rd quarter valued at $136,743,000. Finally, Amundi boosted its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock worth $1,119,448,000 after buying an additional 193,096 shares during the last quarter. Institutional investors own 83.64% of the company's stock.
Insider Buying and Selling at Intuitive Surgical
In related news, Director Gary S. Guthart sold 20,095 shares of the business's stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the completion of the transaction, the director owned 1,204,530 shares in the company, valued at $543,977,793.30. The trade was a 1.64% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the sale, the vice president owned 1,026 shares of the company's stock, valued at approximately $464,993.46. This trade represents a 79.78% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 39,317 shares of company stock valued at $17,720,016. Insiders own 0.60% of the company's stock.
Analysts Set New Price Targets
Several research analysts have issued reports on the company. Sanford C. Bernstein reissued an "outperform" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. Barclays reiterated an "overweight" rating and set a $500.00 target price (up from $485.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Oppenheimer reaffirmed an "outperform" rating and set a $500.00 price objective on shares of Intuitive Surgical in a research report on Wednesday, October 21st. Piper Sandler reaffirmed an "overweight" rating on shares of Intuitive Surgical in a report on Friday, August 21st. Finally, TD Cowen reaffirmed a "buy" rating and issued a $485.00 target price on shares of Intuitive Surgical in a report on Monday, October 19th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $495.90.
Get Our Latest Research Report on ISRG
Intuitive Surgical News Summary
Investors following ISRG have been watching these news items:
- Positive Sentiment: BTIG raised its price target to $513 from $454 and maintained a Buy rating, signaling increased analyst confidence in potential upside. BTIG analyst rating
- Neutral Sentiment: Coverage says ISRG was down 1.7% since its earnings report about a month ago and points investors to upcoming earnings estimates for clues on a possible rebound, without providing a specific estimate change. ISRG performance since earnings
- Negative Sentiment: A valuation analysis says the shares may be near fair value despite strong revenue growth, citing competitive pressure and new robotic platforms that could limit upside. Valuation and competition analysis
Intuitive Surgical Stock Performance
NASDAQ ISRG opened at $407.24 on Friday. The company has a market capitalization of $141.17 billion, a P/E ratio of 49.24, a P/E/G ratio of 2.90 and a beta of 1.45. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88. The stock has a 50 day moving average price of $422.91 and a 200-day moving average price of $428.31.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.65 by $0.35. The company had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. Intuitive Surgical's revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.40 earnings per share. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.